These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12866487)

  • 1. Does Viramune = Sustiva?
    Vázquez E
    Posit Aware; 2003; 14(3):23, 37. PubMed ID: 12866487
    [No Abstract]   [Full Text] [Related]  

  • 2. The non-nukes. Sustiva. Viramune. The two major players.
    Lee J
    Posit Aware; 2005; Spec No():12-5. PubMed ID: 15828103
    [No Abstract]   [Full Text] [Related]  

  • 3. What they say about non-nucleoside drugs.
    Posit Aware; 1999; 10(1):35-7. PubMed ID: 11366521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV/AIDS news: comparable anti-HIV antiviral efficacy of Viramune and Efavirenz--the Lancet publishes first large-scale comparison study.
    Meyer-Kleinmann J
    Infection; 2004 Jun; 32(3):7. PubMed ID: 15230276
    [No Abstract]   [Full Text] [Related]  

  • 5. Switch to Viramune safe for some who can't tolerate Sustiva.
    Proj Inf Perspect; 2008 Dec; (47):1. PubMed ID: 19226672
    [No Abstract]   [Full Text] [Related]  

  • 6. [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373068
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():39. PubMed ID: 11373776
    [No Abstract]   [Full Text] [Related]  

  • 8. Substitution for protease inhibitors in HIV therapy.
    Hirschel B
    N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14681514
    [No Abstract]   [Full Text] [Related]  

  • 9. Nevirapine found to be as effective as efavirenz.
    TreatmentUpdate; 2003; 15(2):3-4. PubMed ID: 12693360
    [No Abstract]   [Full Text] [Related]  

  • 10. Report from the Tenth Retrovirus Conference. Comparing efavirenz and nevirapine: the 2NN study.
    Sax PE
    AIDS Clin Care; 2003 Apr; 15(4):32. PubMed ID: 12712946
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of NNRTIs in antiretroviral-experienced patients.
    Maggiolo F
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():10-7. PubMed ID: 11589823
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-nucleoside reverse transcriptase inhibitors--an overview.
    Bell C; Matthews GV; Nelson MR
    Int J STD AIDS; 2003 Feb; 14(2):71-7. PubMed ID: 12662384
    [No Abstract]   [Full Text] [Related]  

  • 14. Other issues: penetration into sanctuary sites, immune reconstitution and NNRTI sequencing.
    Stellbrink HJ
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():25-32. PubMed ID: 11589825
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors affecting adherence and convenience in antiretroviral therapy.
    Lafeuillade A
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824
    [No Abstract]   [Full Text] [Related]  

  • 16. Can early failure with nevirapine be rescued with efavirenz?
    Briones C; Soriano V; Dona C; Barreiro P; González-Lahoz J
    J Acquir Immune Defic Syndr; 2000 May; 24(1):76-8. PubMed ID: 10877499
    [No Abstract]   [Full Text] [Related]  

  • 17. Efavirenz (Sustiva).
    Res Initiat Treat Action; 2000 Mar; 6(1):22-3. PubMed ID: 11708181
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of NNRTIs in antiretroviral-naïve patients.
    Arribas J
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():3-9. PubMed ID: 11589822
    [No Abstract]   [Full Text] [Related]  

  • 19. What they say about: non-nucleoside drugs.
    Posit Aware; 2000; 11(1):44-7. PubMed ID: 11366350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tolerability of efavirenz after nevirapine-related adverse events.
    Clarke S; Harrington P; Barry M; Mulcahy F
    Clin Infect Dis; 2000 Sep; 31(3):806-7. PubMed ID: 11017835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.